» Articles » PMID: 35860651

Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19

Abstract

Peripheral blood smear is a simple laboratory tool, which remains of invaluable help for diagnosing primary and secondary abnormalities of blood cells despite advances in automated and molecular techniques. Red blood cells (RBCs) abnormalities are known to occur in many viral infections, typically in the form of mild normo-microcytic anemia. While several hematological alterations at automated complete blood count (including neutrophilia, lymphopenia, and increased red cell distribution width-RDW) have been consistently associated with severity of COVID-19, there is scarce information on RBCs morphological abnormalities, mainly as case-reports or small series of patients, which are hardly comparable due to heterogeneity in sampling times and definition of illness severity. We report here a systematic evaluation of RBCs morphology at peripheral blood smear in COVID-19 patients within the first 72 h from hospital admission. One hundred and fifteen patients were included, with detailed collection of other clinical variables and follow-up. A certain degree of abnormalities in RBCs morphology was observed in 75 (65%) patients. Heterogenous alterations were noted, with spiculated cells being the more frequent morphology. The group with >10% RBCs abnormalities had more consistent lymphopenia and thrombocytopenia compared to those without abnormalities or <10% RBCs abnormalities ( < 0.018, and < 0.021, respectively), thus underpinning a possible association with an overall more sustained immune-inflammatory "stress" hematopoiesis. Follow-up analysis showed a different mortality rate across groups, with the highest rate in those with more frequent RBCs morphological alterations compared to those with <10% or no abnormalities (41.9%, vs. 20.5%, vs. 12.5%, respectively, = 0.012). Despite the inherent limitations of such simple association, our results point out towards further studies on erythropoiesis alterations in the pathophysiology of COVID-19.

Citing Articles

Haematological Manifestations of SARS-CoV-2: Insights into Erythropoiesis, Hepcidin Regulation, and Cytokine Storm.

Parham E, Ahmad M, Falasca M Int J Mol Sci. 2025; 26(3).

PMID: 39940645 PMC: 11817086. DOI: 10.3390/ijms26030874.


A Review of the Hematological Picture of Severe COVID-19 Infection.

Amoroso D, Bongo S, Copponi A, Rossi V, Di Giorgio R, Bernardini S Cureus. 2025; 17(2):e78797.

PMID: 39931501 PMC: 11808344. DOI: 10.7759/cureus.78797.


Red Blood Cell Morphology Is Associated with Altered Hemorheological Properties and Fatigue in Patients with Long COVID.

Grau M, Presche A, Kruger A, Bloch W, Haiduk B Biology (Basel). 2024; 13(11).

PMID: 39596903 PMC: 11592038. DOI: 10.3390/biology13110948.


Laboratory Biochemical and Hematological Parameters: Early Predictive Biomarkers for Diagnosing Hepatitis C Virus Infection.

Bagheri S, Fard G, Talkhi N, Rashidi Zadeh D, Mobarra N, Mousavinezhad S J Clin Lab Anal. 2024; 38(24):e25127.

PMID: 39569979 PMC: 11659729. DOI: 10.1002/jcla.25127.


Morphology and Function of Red Blood Cells in COVID-19 Patients: Current Overview 2023.

Jung F, Connes P Life (Basel). 2024; 14(4).

PMID: 38672731 PMC: 11051426. DOI: 10.3390/life14040460.


References
1.
Sun D, Zhang D, Tian R, Li Y, Wang Y, Cao J . The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?. Clin Chim Acta. 2020; 508:122-129. PMC: 7224669. DOI: 10.1016/j.cca.2020.05.027. View

2.
Gerard D, Ben Brahim S, Lesesve J, Perrin J . Are mushroom-shaped erythrocytes an indicator of COVID-19?. Br J Haematol. 2021; 192(2):230. DOI: 10.1111/bjh.17127. View

3.
Girelli D, Marchi G, Busti F, Vianello A . Iron metabolism in infections: Focus on COVID-19. Semin Hematol. 2021; 58(3):182-187. PMC: 8305218. DOI: 10.1053/j.seminhematol.2021.07.001. View

4.
Zhou M, Qi J, Li X, Zhang Z, Yao Y, Wu D . The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis. Br J Haematol. 2020; 189(3):438-441. DOI: 10.1111/bjh.16655. View

5.
Brodin P . Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021; 27(1):28-33. DOI: 10.1038/s41591-020-01202-8. View